Videos

Dr. Suneel Kamath discusses the importance of biomarker-driven approaches in cancer care following the 2026 ASCO GI Symposium.

Dr. Tracy Proverbs-Singh explains that caregivers may neglect screenings, medications, rest, and hydration, risking their own health.

Dr. Tracy Proverbs-Singh explains how a multidisciplinary team helps patients with GI cancers manage digestion, absorb nutrients and maintain energy during treatment.

Being a multiple myeloma care partner involves significant logistical and emotional challenges.

Shared decision-making empowers multiple myeloma patients and their care partners to actively collaborate with the medical team on treatment choices.

Dr. Anne Peled shares advice for patients and dispelled myths related to cancer survivorship.

Discover inspiring messages of hope from cancer survivors, emphasizing resilience, scientific advancements, and the importance of community support.

Explore the evolving landscape of myeloma treatment, focusing on maintenance therapies and patient experiences with innovative drug combinations.

For Ashliann Mazeika, a diagnosis at 24 led to a decade-long treatment journey affirmed by the Breast Cancer Index test.

Dr. Anne Peled co-developed the sensation-preserving mastectomy she received after her second diagnosis of breast cancer.

A vaccine combined with Keytruda is associated with a 49% reduction in the risk of recurrence or death.

Modern multiple myeloma treatment often involves complex combination therapies, which significantly impact daily life for patients and care partners.

Ensuring medication adherence for multiple myeloma treatment involves both practical systems and a patient-centered mindset.

For Richard “Rocky” Kimball, a diagnosis of myelodysplastic syndromes, or MDS, necessitated a number of lifestyle changes.

Dr. Nicholas Hornstein explained the concept of ctDNA and how this blood test may help guide treatment decisions, including whether additional therapy is needed.

CURE spoke with Dr. Robert Alter of John Theurer Cancer Center about the best time to explore clinical trials.

During the Blood Cancer Heroes Event, Joe McDonough shared his excitement at being among individuals making meaningful contributions to others’ lives.

Dr. William A. Hall sat down with CURE to discuss the impact of technologies like artificial intelligence on gastrointestinal cancer care.

CURE sat down with Dr. Surbhi Sidana to discuss this treatment combination.

Oya Gilbert, diagnosed with myeloma in 2017, uses advocacy and music to improve awareness, access and support for patients with cancer.

Patients share their experiences with myeloma relapses, discussing coping strategies, emotional challenges, and the importance of proactive communication with doctors.

Patients share their personal journeys and insights on the decision-making process surrounding transplant options for cancer treatment.

At Keck Medicine of USC, surgeons, oncologists and radiation specialists collaborate closely, ensuring individualized care for patients with lung cancer.

Joe McDonough reflects on the bonds he’s formed in the childhood cancer community and what they’ve taught him about empathy and shared experience.

Dr. Elena Elimova discussed data showing 21-month progression-free survival with Ziihera, Tevimbra and chemotherapy for some patients.

Kyle Donahue, who enrolled in a clinical trial at Brigham and Women's Hospital, is now a five-year survivor of brain cancer.

Dr. Benjamin Jon Golas explains that surgery, chemotherapy and radiation form the foundation of curative-intent treatment for patients with pancreas cancer.

Dr. Nadine A. Jackson explains how relatively simple interventions may help close gaps in access to genomics-driven trials across gastrointestinal cancers.

With multiple myeloma treatment evolving rapidly, the role of the care partner in managing the complexity of multiple myeloma is more crucial than ever.

In this segment, multiple myeloma care partners direct others to vital sources of hope and practical information.